Atomo Diagnostics Limited (ASX:AT1)
Australia · Delayed Price · Currency is AUD 0.0300
-0.0020 (-6.25%)
Apr 7, 2026, 4:10 PM AEST
Atomo Diagnostics Revenue
Atomo Diagnostics had revenue of 2.18M AUD in the half year ending December 31, 2025, with 13.37% growth. This brings the company's revenue in the last twelve months to 3.92M, down -7.00% year-over-year. In the fiscal year ending June 30, 2025, Atomo Diagnostics had annual revenue of 3.79M, down -7.20%.
Revenue (ttm)
3.92M
Revenue Growth
-7.00%
P/S Ratio
6.20
Revenue / Employee
46.12K
Employees
85
Market Cap
24.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 3.79M | -294.18K | -7.20% |
| Jun 30, 2024 | 4.09M | 1.54M | 60.65% |
| Jun 30, 2023 | 2.54M | -9.79M | -79.38% |
| Jun 30, 2022 | 12.34M | 5.62M | 83.69% |
| Jun 30, 2021 | 6.72M | 1.35M | 25.09% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nova Eye Medical | 33.05M |
| CleanSpace Holdings | 20.66M |
| Micro-X | 16.90M |
| ImpediMed | 14.23M |
| CurveBeam AI | 12.15M |
| Control Bionics | 6.07M |
| CONNEQT Health | 5.80M |
| OncoSil Medical | 3.72M |
Atomo Diagnostics News
- 7 months ago - Atomo Diagnostics Ltd (ASX:AT1) Full Year 2025 Earnings Call Highlights: Navigating Challenges ... - GuruFocus